The pharmaceutical executive Martin Shkreli made headlines this summer when he raised the price of a generic drug by over 5,000 percent. Led by Clay Wiske MD ’16, a team of researchers presented ...
Rising prescription costs and pharmacy closures are making it harder for many Americans to afford and access their ...
A new analysis has raised concerns about the Cigna Group’s drug pricing strategy, finding that one of its subsidiaries, Quallent Pharmaceuticals, often charges more for generic medications than ...
Even as drug shortages squeeze the pharmaceutical industry and weigh on patients, one of the world’s top generic manufacturers is planning to cut parts of its portfolio. At Teva’s recent investor day, ...
DUBLIN--(BUSINESS WIRE)--The "Patent Strategies for Generic Medicines and Generic Medicine Companies Training Course (Oct 21, 2025)" has been added to ResearchAndMarkets.com's offering. In the highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback